SOPHARMA AD: Preliminary sales revenue data for July 2026

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No

/

2026

Date of issue:

2026-08-20

Short name of the issuer

SOPHARMA AD

Subject

Preliminary sales revenue data for July 2026

Official market - legal basis

Art. 56 ust. 1 pkt 2 Ustawy o ofercie – informacje bieї№ce i okresowe

Unofficial market - legal basis

Contents of the report:

Sofia, Bulgaria, August 20, 2026 – “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) pursuant to the requirements of art. 100t of the Law on Public Offering of Securities (LPOS), hereby informs that in July 2026 the Company reported a 103% increase in sales compared to the same month of the previous year, including a 31% increase in domestic sales and a 151% increase in export sales.

For the period from the beginning of 2026 through the end of July, the Company reported a 52% increase in sales compared to the same period of the previous year, including a 2% increase in domestic sales and an 82% increase in export sales.

Annexes

File

Description

INSIDE_SFA_July_2026_Sales_20082026_EN.rar

Preliminary sales revenue data for July 2026

Legal framework

Type of information

RegulatoryData

Collection Body

PLKNF

Unique data record identifier

Type of submission

Correction (to be used when information previously reported is found to be incorrect and should be corrected)

Voluntary information flag

Date or period covered [Date or beginning of the period to which the information relates]

2026-07-01

Date or period covered [Date or end of the period to which the information relates]

2026-07-31

Personal data flag

Macierzyste państwo członkowskie, w stosownych przypadkach

PL

DocumentReference

Język, w którym przekazano informacje

Oryginał (ORIG) czy tłumaczenie (TRAN)

Numer referencyjny pliku danych

PL

ORIG

SubmittingEntity

Submitting entity LEI

or

Submitting entity name - natural person

RelatedEntity/LegalPerson

Entity LEI

Size of the entity

Industry sector(s)

097900BGGW0000048796

Large undertaking

(acc. NACE): C

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification

of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

nd

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

2026-08-20

Ognian Ivanov Donev

Executive Director